MedTrace Logo

Evaluation of the Efficacy of 0.8% Hyaluronic Acid Gel

NCT03311906 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2018-03-05

No results posted yet for this study

Summary

assess the clinical and laboratory effects of the local and sub gingival application of a 0.8% hyaluronic acid gel (GENGIGEL®) as an adjunct to scaling and root planning (SRP) in chronic moderate to severe periodontitis patients as indicated by expression of Human Beta Definsin-2 (HBD2) in gingival crevicular fluid (GCF).

Conditions

  • Periodontitis

Interventions

DRUG

0.8% Hyaluronic Acid

Application of 0.8% hyaluronic acid after scaling and root planing

PROCEDURE

Scaling and Root Planing

Scaling of the teeth using hand and ultrasonic scalers followed by planing of the root with curettes

Sponsors & Collaborators

  • Riyadh Colleges of Dentistry and Pharmacy

    lead OTHER

Principal Investigators

  • Sanaa M Shafshak, PhD · Riyadh Colleges of Dentistry and Pharmacy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-15
Primary Completion
2017-08-15
Completion
2017-10-02
FDA Drug
Yes

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03311906 on ClinicalTrials.gov